Search results for "intercellular adhesion molecule-1"

showing 10 items of 106 documents

Hypothermic preservation of lung allograft inhibits cytokine-induced chemoattractant-1, endothelial leucocyte adhesion molecule, vascular cell adhesi…

2007

Summary Organ dysfunction is a major clinical problem after lung transplantation. Prolonged cold ischaemia and reperfusion injury are believed to play a central role in this complication. The influence of cold preservation on subsequent warm reperfusion was studied in an isolated, ventilated and perfused rat lung. Rat lungs were flushed with cold Perfadex-solution and stored at 4°C for different time periods. Thereafter lungs were perfused and ventilated for up to 3 h. Physiological parameters, production of inflammatory mediators and leucocyte infiltration were measured before and after perfusion. Lungs subjected to a cold ischaemia time of up to 6 h showed stable physiological conditions …

ChemokinePathologymedicine.medical_specialtymedicine.medical_treatmentImmunologyIntercellular Adhesion Molecule-1Vascular Cell Adhesion Molecule-1Blood PressurePulmonary EdemaPulmonary ArteryBasic ImmunologyHypothermia InducedmedicineImmunology and AllergyAnimalsRespiratory systemRats WistarLungChemokine CCL2LungbiologyCell adhesion moleculemedicine.diseaseIntercellular Adhesion Molecule-1RatsEndothelial stem cellCytokinemedicine.anatomical_structureReperfusion InjuryImmunologybiology.proteinLeukocytes MononuclearTissue PreservationInflammation MediatorsE-SelectinReperfusion injuryCell Adhesion MoleculesLung Transplantation
researchProduct

“Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-me…

2008

Abstract We studied the effect of leukotriene D(4) (LTD(4)) on a human bronchial epithelial cell line (16HBE) overexpressing the cysteinyl leukotriene (CysLT) (1) receptor (HBECysLT(1)R), looking at the associated signal transduction mechanisms as well as at effects on inflammatory cell adhesion. The results obtained showed that LTD(4) increases the phosphorylation of extracellular signal-regulated protein kinase (ERK) 1/2 and of the signal transducer and activator of transcription 1 (STAT-1) in serine 727 (STAT-1Ser727), resulting in increased eosinophil adhesion to HBECysLT(1)R, associated with enhanced surface expression of intercellular adhesion molecule (ICAM) 1. Pretreatment with a Cy…

CyclopropanesMAPK/ERK pathwayIndolesBronchiAcetatesSulfidesBiologyCysteinyl leukotriene-1cysteinyl leukotrieneCell LineLeukotriene D4MaleimidesInterferon-gammaCell AdhesionHumansProtein kinase ACells CulturedProtein kinase CReceptors LeukotrienePharmacologyKinaseMEK inhibitorMembrane ProteinsEpithelial CellsIntercellular Adhesion Molecule-1Intercellular adhesion moleculeCell biologyEosinophilsSTAT1 Transcription FactorQuinolinesLeukotriene AntagonistsMolecular MedicinePhosphorylationMitogen-Activated Protein KinasesSignal transduction
researchProduct

Endothelin-1 modulates the expression of adhesion molecules on fibroblast-like synovial cells (FLS)

1996

Endothelin-1 is known to possess various biological properties. In the present study we have investigated the effects of Endothelin-1 (Et-1) on the expression of adhesion molecules ICAM-1, VCAM-1 and CD-44 by fibroblast-like synoviocytes. Cultured fibroblast-like synoviocytes were treated with Et-1 in the absence or presence of C1306, a specific endothelin-A-receptor antagonist. Cell surface expression of ICAM-1, VCAM-1 and CD-44 was determined by immunofluorescence studies, Cyto-ELISA and FACS-analysis. ICAM-1, VCAM-1 and CD-44 were constitutively expressed on cultured FLS. After incubation with Et-1 the expression of ICAM-1, VCAM-1 and CD-44 increased. The level of expression of adhesion …

Endothelin Receptor Antagonistsmedicine.medical_specialtymedicine.medical_treatmentImmunologyVascular Cell Adhesion Molecule-1BiologyProinflammatory cytokineRheumatologyDownregulation and upregulationInternal medicinemedicineHumansImmunology and AllergyCells CulturedEndothelin-1Tumor Necrosis Factor-alphaCell adhesion moleculeSynovial MembraneGeneral MedicineAdhesionFibroblastsIntercellular Adhesion Molecule-1Receptor Endothelin AIn vitroCell biologyHyaluronan ReceptorsCytokinemedicine.anatomical_structureEndocrinologyCell cultureSynovial membraneCell Adhesion MoleculesInterleukin-1
researchProduct

α-Lipoic acid reduces expression of vascular cell adhesion molecule-1 and endothelial adhesion of human monocytes after stimulation with advanced gly…

1999

Advanced glycation end products (AGEs) have been identified as relevant mediators of late diabetic complications such as atherosclerotic disease. The endothelial migration of monocytes is one of the first steps in atherogenesis and monocyte-endothelial interaction itself is linked to the expression of adhesion molecules like vascular cell adhesion molecule-1 (VCAM-1). Recently, stimulation of VCAM-1 by AGEs has been demonstrated. Since endothelial stimulation by AGEs is followed by generation of oxygen free radicals with subsequent activation of nuclear transcription factor kappaB, we investigated the influence of alpha-lipoic acid on the expression of VCAM-1 and monocyte adherence to endot…

EndotheliumCell adhesion moleculeMonocyteCellIntercellular Adhesion Molecule-1General MedicineBiologyMolecular biologyEndothelial stem cellmedicine.anatomical_structureBiochemistryGlycationmedicineCell adhesionClinical Science
researchProduct

Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants.

1998

Although nitric oxide (NO) and antioxidants inhibit adhesion molecule expression, their inhibitory effects on nuclear factor kappaB (NF-kappaB) activation may differ. The NO donors, but not 8-bromo-cGMP, decreased tumor necrosis factor alpha (TNF-alpha)-induced VCAM-1, ICAM-1, and E-selectin expression by 11-70%. In contrast, NAC completely abolished VCAM-1 and E-selectin expression and decreased ICAM-1 expression by 56%. Gel shift assays demonstrate that NF-kappaB activation was inhibited by both NO and antioxidants. The activation of NF-kappaB involves the phosphorylation and degradation of its cytoplasmic inhibitor IkappaB-alpha by 26S proteasomes. The 26S proteasome inhibitor MG132 prev…

EndotheliumImmunologyVascular Cell Adhesion Molecule-1IκB kinaseBiologyProtein Serine-Threonine KinasesNitric OxideAntioxidantsNitric oxidechemistry.chemical_compoundMiceNF-KappaB Inhibitor alphaMG132medicineImmunology and AllergyAnimalsHumansPromoter Regions GeneticCells CulturedI-Kappa-B KinaseNF-kappa BCell BiologyIntercellular Adhesion Molecule-1Molecular biologyI-kappa B KinaseDNA-Binding Proteinsmedicine.anatomical_structurechemistryProteasomePhosphorylationTumor necrosis factor alphaI-kappa B ProteinsEndothelium VascularE-SelectinCell Adhesion MoleculesJournal of leukocyte biology
researchProduct

Endothelial adhesion molecules in essential hypertension: response to arginine infusion

2001

EndotheliumbiologyArginineCell adhesion moleculebusiness.industryIntercellular Adhesion Molecule-1Soluble cell adhesion moleculesPharmacologymedicine.diseaseEssential hypertensionmedicine.anatomical_structureE-selectinInternal Medicinemedicinebiology.proteinEndothelial dysfunctionbusinessAmerican Journal of Hypertension
researchProduct

Cohen syndrome is associated with major glycosylation defects

2014

International audience; Cohen syndrome (CS) is a rare autosomal recessive disorder with multisytemic clinical features due to mutations in the VPS13B gene, which has recently been described encoding a mandatory membrane protein involved in Golgi integrity. As the Golgi complex is the place where glycosylation of newly synthesized proteins occurs, we hypothesized that VPS13B deficiency, responsible of Golgi apparatus disturbance, could lead to glycosylation defects and/or mysfunction of this organelle, and thus be a cause of the main clinical manifestations of CS. The glycosylation status of CS serum proteins showed a very unusual pattern of glycosylation characterized by a significant accum…

GlycanGlycosylationGlycosylationEndosomeDevelopmental Disabilities[SDV]Life Sciences [q-bio]Vesicular Transport ProteinsGolgi ApparatusFingers03 medical and health scienceschemistry.chemical_compoundsymbols.namesake0302 clinical medicineAntigens CDIntellectual DisabilityMyopiaGeneticsHumansObesityMolecular BiologyGenetics (clinical)030304 developmental biology0303 health sciencesbiology[ SDV ] Life Sciences [q-bio]Retinal DegenerationTransferrinGeneral MedicineFibroblastsBrefeldin AGolgi apparatusIntercellular Adhesion Molecule-1Cell biologyVPS13BchemistryMembrane proteinBiochemistryMicrocephalysymbolsO-linked glycosylationbiology.proteinMuscle HypotoniaElectrophoresis Polyacrylamide GelRNA InterferenceCell Adhesion Molecules030217 neurology & neurosurgery
researchProduct

The influence of advanced glycation endproducts (AGE) on the expression of human endothelial adhesion molecules.

1998

Advanced glycation endproducts (AGEs) possibly play a dominant role in the pathogenesis of macrovascular disease in diabetes. Recent studies could demonstrate that glycated albumin (AGE-BSA) was able to stimulate vascular cell adhesion molecule-1 (VCAM.1) on endothelial cells. The aim of this study was to find out if AGE-BSA was not only able to enhance the expression of vascular cell adhesion molecule-1, but also of intercellular adhesion molecule-1 (ICAM-1) and E-Selectin on human endothelial cells. Stimulation of endothelial cells with AGE-BSA for six hours predominantly increased the expression of VCAM-1, but ICAM-1 and E-Selectin were also upregulated as shown by immunoilluminometric a…

Glycation End Products AdvancedTranscription GeneticEndocrinology Diabetes and MetabolismIntercellular Adhesion Molecule-1Gene ExpressionVascular Cell Adhesion Molecule-1BiologyPolymerase Chain ReactionEndocrinologyGlycationAlbuminsE-selectinInternal MedicinemedicineHumansCell adhesionMacrovascular diseaseDose-Response Relationship DrugCell adhesion moleculeGeneral MedicineAdhesionmedicine.diseaseIntercellular Adhesion Molecule-1ImmunohistochemistryEndothelial stem cellImmunologyLuminescent Measurementsbiology.proteinCancer researchEndothelium VascularE-SelectinExperimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
researchProduct

Comparative Studies on Vascular Endothelium in vitro

1995

Recent studies have presented evidence that the processes of hypoxaemia and reperfusion are involved in several pathogenetic mechanisms of atherosclerotic lesions. The ability of hypoxaemia to activate circulating white blood cells (WBCs) and enhance WBC-endothelial cell (EC) interactions is suspected to be a major factor in deleterious processes in the blood vessel wall. Various groups have suggested that cell adhesion molecules (CAMs), such as ICAM-1, VCAM-1 and E-selectin and their leukocyte ligands are involved in intercellular activities of the relevant cell types. We studied the effects of different oxygen tensions, simulating normoxic conditions, hypoxia and hyperoxia in vitro with t…

HyperoxiabiologyChemistryCell adhesion moleculemedicine.medical_treatmentIntercellular Adhesion Molecule-1Cell BiologyGeneral MedicineHypoxia (medical)Pathology and Forensic MedicineOxygen tensionCell biologyEndothelial stem cellCytokineE-selectinbiology.proteinmedicinemedicine.symptomMolecular BiologyPathobiology
researchProduct

The endocannabinoid 2-arachidonoylglycerol inhibits endothelial function and repair

2021

Abstract Background Endothelial dysfunction promotes atherogenesis, vascular inflammation, and thrombus formation. Reendothelialization after angioplasty is required in order to prevent stent failure. Previous studies have highlighted the role of 2-arachidonoylglycerol (2-AG) in murine experimental atherogenesis and in human coronary artery disease. However, the impact of 2-AG on endothelial repair and leukocyte–endothelial cell adhesion is still unknown. Methods Endothelial repair was studied in two treatment groups of wildtype mice following electrical injury of the common carotid artery. One group received the monoacylglycerol lipase (MAGL)-inhibitor JZL184, which impairs 2-AG degradatio…

ICAM-1Cell adhesion moleculebusiness.industryIntercellular Adhesion Molecule-1030204 cardiovascular system & hematologyPharmacologymedicine.diseaseEndothelial stem cell03 medical and health scienceschemistry.chemical_compound0302 clinical medicinemedicine.anatomical_structurechemistrymedicine030212 general & internal medicineEndothelial dysfunctionVCAM-1Cardiology and Cardiovascular MedicineCell adhesionbusinessArteryInternational Journal of Cardiology
researchProduct